Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence-Reference-Cited by-同舟云学术

Antibody response of smokers to the COVID-19 vaccination: Evaluation based on cigarette dependence

Published:2022-04-30 Issue:2 Volume:16 Page:78-84
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Mori Yukihiro¹,Tanaka Mamoru²,Kozai Hana²,Hotta Kiyoshi³,Aoyama Yuka⁴,Shigeno Yukihiro⁵,Aoike Makoto¹,Kawamura Hatsumi¹,Tsurudome Masato¹,Ito Morihiro⁶

Affiliation:

1. Graduate School of Life and Health Sciences, Chubu University, Aichi, Japan.

2. Department of Food and Nutritional Sciences, College of Bioscience and Biotechnology, Chubu University, Aichi, Japan.

3. Center for Nursing Practicum Support, Chubu University, Aichi, Japan.

4. Department of Clinical Engineering, College of Life and Health Sciences, Chubu University, Aichi, Japan.

5. Center for Emergency Medical Technician Practicum Support, Chubu University, Aichi, Japan.

6. Department of Biomedical Sciences, College of Life and Health Science, Chubu University, Aichi, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/16/2/16_2022.01022/_pdf

Reference41 articles.

1. 1. Poon LLM, Peiris M. Emergence of a novel human coronavirus threatening human health. Nat Med. 2020; 26:317-319.

2. 2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020; 383:2603-2615.

3. 3. Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020; 383:2439-2450.

4. 4. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020; 367:1444-1448.

5. 5. Brouwer PJM, Caniels TG, van der Straten K, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020; 369:643-650.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Status and COVID-19 Epidemiology in an Inland Region of Portugal: A Retrospective Study;International Journal of Environmental Research and Public Health;2024-08-06

2. Acceptance and Attitudes towards Covid-19 Vaccines: A Cross-Sectional Study from India;Biosciences Biotechnology Research Asia;2023-12-31

3. Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021–2022;Swiss Medical Weekly;2023-12-22

4. A Systematic Evaluation of the SARS-CoV-2 Vaccine-Induced Anti-S-RBD-Ig Response in a Population of Health Care Workers;Vaccines;2023-09-07

5. Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys® Immunoassay in the S Protein Vaccination Era;Viruses;2023-04-07